Saturday 17 October 2026
Export XXII’s income statement to Excel — free account
22nd Century Group, Inc
XXII Consumer Defensive Tobacco
22nd Century Group, Inc’s revenue for fiscal 2025 (year ended December 2025) was $17.6 million, down 27.9% from fiscal 2024. In the quarter to June 2026, revenue fell 29.9%, EPS grew 97.5%, free cash flow fell 57.4% and total debt fell 88.6%, each against the same quarter a year earlier.
0.34
0.29
−46.03%
Follow XXII
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.06 | 0.08 | 0.12 | 0.33 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(0.21) | (0.42) | 0.77 | (1.49) | |
P/B ratio |
0.05 | 0.06 | 0.13 | 0.33 | |
Price to Tangible BV |
0.07 | 0.09 | 0.22 | 0.49 | |
EV/Sales |
(0.11) | (0.29) | (0.07) | 0.53 | |
EV/EBITDA |
0.14 | 0.42 | 0.13 | 0.00 | |
EV/Operating CF |
0.19 | 0.58 | 0.17 | (0.64) | |
EV/FCF |
0.16 | 0.57 | 0.17 | (0.67) | |
Quick Ratio |
1.49 | 1.81 | 1.48 | 0.74 | |
Current Ratio |
2.61 | 2.67 | 2.42 | 2.17 | |
Net Debt/EBITDA |
1.85 | 3.25 | 2.61 | 1.67 | |
Debt/Assets |
1.70% | 1.57% | 1.87% | 0.00% | |
Debt/Equity |
0.02 | 0.02 | 0.03 | 0.00 | |
Asset Turnover |
0.60 | 0.61 | 0.72 | 0.62 | |
Operating CF/Net income |
0.18 | 0.29 | (0.37) | (0.73) | |
Capex/Depreciation |
(1.34) | (0.19) | (2.94) | (0.07) | |
Interest Coverage |
(193.59) | (276.27) | (233.58) | (6.01) | |
Research and Development Expense of Revenue |
10.30% | 6.94% | 3.00% | 4.81% | |
Selling, General and Administrative Expense of Revenue |
94.38% | 51.60% | 51.57% | 46.10% | |
Intangible Assets out of Total Assets |
0.23 | 0.20 | 0.23 | 0.19 | |
Share Based Compensation of Revenue |
9.43% | 5.80% | 5.54% | 2.29% | |
Graham Net Nets |
10.97 | 9.09 | 4.28 | 1.95 | |
Graham Number |
6,195.29 | 15,587.83 | 0.00 | 229,516.33 | |
Earnings Yield |
472,691.31% | 34,314.57% | (737.72%) | 296,626.24% | |
Free Cash Flow Yield |
(1,123.62%) | (603.04%) | (368.34%) | (238.02%) | |
Revenue per Share |
13.69 | 137.75 | 384.46 | 339.92 | |
Operating CF per Share |
(19.07) | (104.13) | 298.80 | (340.51) | |
Capex per Share |
(1.60) | (1.58) | (82.07) | (1.86) | |
Free Cash Flow per Share |
(20.67) | (105.70) | 216.74 | (342.37) | |
Cash per Share |
28.96 | 320.30 | 777.07 | 410.68 | |
Shareholders Equity per Share |
89.11 | 712.01 | 2,010.00 | 1,788.47 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
89.11 | 712.01 | 2,010.00 | 1,788.47 | |
Free Cash Flow |
(4.32) | (3.15) | 1.99 | (4.04) | |
Working Capital |
10.37 | 13.16 | 10.36 | 12.38 | |
Capital Expenditures |
(0.33) | (0.05) | (0.75) | (0.02) | |
Net Current Asset Value |
9.29 | 11.98 | 9.10 | 11.66 | |
EV/EBIT |
0.13 | 0.38 | 0.11 | 0.00 | |
Capex to Sales |
0.12 | 0.01 | 0.21 | 0.01 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
3.56 | 4.55 | 2.65 | 2.39 | |
Average Payables |
1.79 | 2.06 | 1.70 | 2.85 | |
Average Inventory |
3.52 | 3.45 | 3.17 | 2.62 | |
Average Assets |
24.27 | 25.88 | 24.35 | 29.27 | |
Average Common Equity |
12.14 | 12.42 | 9.89 | 10.92 |
Columns are period end dates